ReviewEndocrine-related cancer2022

Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancers.

Marie-Claude Hofmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.